Amyris Can't Force Arbitration in Patent Suit With CBD Company - Bloomberg Law

Retrieved on: 2022-09-15 21:11:16

Tags for this article:

Click the tags to see associated articles and topics

Amyris Can't Force Arbitration in Patent Suit With CBD Company - Bloomberg Law. View article details on hiswai:

Excerpt

Biotech company Amyris Inc. can't force Lavvan Inc., which creates cannabinoids ingredients, to arbitrate a trade secrets and patent infringement ...

Article found on: news.bloomberglaw.com